Multilevel Mediation Analysis to Explore Racial Disparities in Breast Cancer Recurrence and Survival using CDC Special Studies
使用 CDC 特别研究进行多级中介分析以探索乳腺癌复发和生存的种族差异
基本信息
- 批准号:9439441
- 负责人:
- 金额:$ 43.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-24 至 2021-09-23
- 项目状态:已结题
- 来源:
- 关键词:AddressAdjuvantAfrican AmericanAmericanBehavioralBreastBreast Cancer DetectionBreast Cancer PatientCancer BurdenCancer EtiologyCancer PatientCaringCensusesCenters for Disease Control and Prevention (U.S.)Cessation of lifeCharacteristicsComorbidityComplexComputer softwareDataData SetData SourcesDatabasesDeath RateDietEconomicsFemale Breast CarcinomaFundingGoalsHealth systemHealthcareHealthy People 2020HospitalsIncidenceIndividualInstitute of Medicine (U.S.)InstitutesInterventionKnowledgeLinkLouisianaMalignant NeoplasmsMeasuresMediationMediator of activation proteinMedicareMethodologyMethodsModelingNational Cancer InstituteNational Cancer ProgramNeighborhoodsOutcomes ResearchParticipantPatient CarePatient-Focused OutcomesPatterns of CarePhysical activityPhysiciansPopulationProstateProviderPublic HealthRaceRecording of previous eventsRecurrenceReportingResearchResearch PersonnelResearch Project GrantsResourcesRisk FactorsSeriesSocietiesSourceStatistical MethodsStructureSurvival RateTestingTreesUnited StatesUnited States Dept. of Health and Human ServicesVisual AidWomananalytical methodbreast cancer survivalcancer diagnosiscancer health disparitycancer recurrencecancer survivalcancer typecomparative effectivenessdata registrydata structuredisorder preventiondisparity reductioneffective therapyeffectiveness researchhazardhealth disparityimprovedmalignant breast neoplasmminority healthmodifiable riskneoplasm registrynovelnovel strategiesprecision medicineracial disparityresearch studyresidenceresponsescreeningsocialstandard of caresurvival outcometumortumor registry
项目摘要
Breast cancer is the most common cancer and the second leading cause of cancer death
among American women of all races. Despite improvement of recurrence and survival rates of
breast cancer in the United States, significant differences between white and black women remain.
Previous studies have found that more advanced and aggressive tumors and less than optimal
treatment may explain the higher recurrence and lower survival rates for black women as
compared to white women. However, to the best of our knowledge, there has been no research
that jointly considers potential factors that include not only individual level information such as
treatment history and tumor characteristics, but also provider characteristics, and physical and
social environmental information. Due to limitations of current analytic methods and the lack of
comprehensive data sets, researchers have not been able to differentiate the relative effect each
factor contributes to the overall racial disparities at different levels (census tract or individual
levels).
We will use the CDC-funded special studies, including Patterns of Care study, Enhancing
Cancer Registry Data for Comparative Effectiveness Research (CER), and the Patient Centered
Outcomes Research (PCOR), to examine the determinants of racial disparities in breast cancer
survival and recurrence using a novel multilevel mediation analysis. The PoC, CER, and PCOR
studies collected complete standard of care and tumor characteristic information for female breast
cancer patients. The Louisiana Tumor Registry participated in all these studies and collected the
required information from Louisiana breast cancer patients. We plan to link the datasets with
census data and many other data sources to obtain environmental and provider information.
We propose a novel statistical method that can jointly consider potentially correlated
multiple mediators, and differentiate the indirect effect from every individual factor from different
levels that may contribute to the race-breast cancer survival and recurrence relationship. If
successful, this proposal will provide the most comprehensive exploration of racial disparities in
breast cancer patients’ recurrence and survival in the United States.
乳腺癌是最常见的癌症,也是癌症死亡的第二大原因
在各种种族的美国妇女中。尽管复发率提高了
在美国,白人和黑人妇女之间存在显着差异。
先前的研究发现,更高级和侵略性的肿瘤和少于最佳
治疗可以解释黑人妇女的较高复发和较低的生存率
与白人妇女相比。但是,据我们所知,没有研究
共同考虑的潜在因素不仅包括个人级别信息,例如
治疗史和肿瘤特征,以及提供者的特征,以及身体和
社会环境信息。由于当前分析方法的局限性以及缺乏
全面的数据集,研究人员无法区分每个
因素有助于不同层面的总体种族分布(人口普查或个人
级别)。
我们将使用CDC资助的特殊研究,包括护理模式,增强
比较有效性研究(CER)的癌症注册表数据,患者以中心为中心
结果研究(PCOR),检查乳腺癌种族差异的决定者
使用新颖的多级中介分析的生存和复发。 POC,CER和PCOR
研究收集了女性乳房的完整护理标准和肿瘤特征信息
癌症患者。路易斯安那州肿瘤登记处参与了所有这些研究,并收集了
需要路易斯安那州乳腺癌患者的信息。我们计划将数据集链接到
人口普查数据和许多其他数据源,以获取环境和提供者信息。
我们提出了一种新的统计方法,可以共同考虑潜在的相关性
多个调解人,并将间接效应与每个单独因素与不同的不同因素区分开
可能有助于种族胸癌的生存和复发关系的水平。如果
成功,该提案将对种族分布提供最全面的探索
乳腺癌患者在美国的复发和生存。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Qingzhao Yu其他文献
Qingzhao Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Qingzhao Yu', 18)}}的其他基金
Trends of disparities in breast cancer progression and health care considering multilevel risk factors
考虑多层次危险因素的乳腺癌进展和医疗保健差异趋势
- 批准号:
10432316 - 财政年份:2022
- 资助金额:
$ 43.8万 - 项目类别:
Trends of disparities in breast cancer progression and health care considering multilevel risk factors
考虑多层次危险因素的乳腺癌进展和医疗保健差异趋势
- 批准号:
10835483 - 财政年份:2022
- 资助金额:
$ 43.8万 - 项目类别:
相似国自然基金
穿透性靶向胰腺癌内cDC1的纳米佐剂调控溶酶体逃逸促进放疗诱导ICD的机制研究
- 批准号:82303680
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多级改造的工程化外泌体自佐剂疫苗平台实现鼻上皮细胞感染拟态和粘膜递送的研究
- 批准号:32371440
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
展示PD-L1抗体的纳米锰佐剂联合放疗以诱导原位肿瘤疫苗的产生及其机制的探究
- 批准号:32371518
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向FPPS的双磷酸疫苗佐剂的开发
- 批准号:82341040
- 批准年份:2023
- 资助金额:100 万元
- 项目类别:专项基金项目
应用于冠状病毒广谱疫苗开发的新型全链式免疫增强型佐剂研究
- 批准号:82341036
- 批准年份:2023
- 资助金额:110 万元
- 项目类别:专项基金项目
相似海外基金
Project 3: Credentialing CDK 4/6 inhibitors used with radiation as an effective treatment strategy in locally advanced ER+ and TNBC
项目 3:认证 CDK 4/6 抑制剂与放射结合使用作为局部晚期 ER 和 TNBC 的有效治疗策略
- 批准号:
10554474 - 财政年份:2023
- 资助金额:
$ 43.8万 - 项目类别:
A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment
对非小细胞肺癌和多发性骨髓瘤患者进行的前瞻性队列研究,以评估治疗期间使用大麻的益处和危害
- 批准号:
10792363 - 财政年份:2023
- 资助金额:
$ 43.8万 - 项目类别:
Baseline host and environmental factors that impact pre-erythrocytic malaria vaccine (hypo)responsiveness in endemic regions
影响流行地区红细胞前疟疾疫苗(低)反应性的基线宿主和环境因素
- 批准号:
10348223 - 财政年份:2022
- 资助金额:
$ 43.8万 - 项目类别:
Baseline host and environmental factors that impact pre-erythrocytic malaria vaccine (hypo)responsiveness in endemic regions
影响流行地区红细胞前疟疾疫苗(低)反应性的基线宿主和环境因素
- 批准号:
10586094 - 财政年份:2022
- 资助金额:
$ 43.8万 - 项目类别:
Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans
非裔美国人三阴性乳腺癌的亚克隆异质性和结果差异
- 批准号:
10596525 - 财政年份:2022
- 资助金额:
$ 43.8万 - 项目类别: